Sedatives for opiate withdrawal in newborn infants
is a topic covered in the Evidence-Based Medicine Guidelines
To view the entire topic, please sign in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
"Sedatives for Opiate Withdrawal in Newborn Infants." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/454265/all/Sedatives_for_opiate_withdrawal_in_newborn_infants.
Sedatives for opiate withdrawal in newborn infants. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/454265/all/Sedatives_for_opiate_withdrawal_in_newborn_infants. Accessed October 19, 2019.
Sedatives for opiate withdrawal in newborn infants. (2019). In Evidence-Based Medicine Guidelines. Available from https://evidence.unboundmedicine.com/evidence/view/EBMG/454265/all/Sedatives_for_opiate_withdrawal_in_newborn_infants
Sedatives for Opiate Withdrawal in Newborn Infants [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2019 October 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/454265/all/Sedatives_for_opiate_withdrawal_in_newborn_infants.
TY - ELEC
T1 - Sedatives for opiate withdrawal in newborn infants
ID - 454265
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/454265/all/Sedatives_for_opiate_withdrawal_in_newborn_infants
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine